| CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity W Fu, C Lei, S Liu, Y Cui, C Wang, K Qian, T Li, Y Shen, X Fan, F Lin, ... Nature communications 10 (1), 4355, 2019 | 399 | 2019 |
| Treatment of murine lupus with TIGIT-Ig S Liu, L Sun, C Wang, Y Cui, Y Ling, T Li, F Lin, W Fu, M Ding, S Zhang, ... Clinical immunology 203, 72-80, 2019 | 31 | 2019 |
| PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy PG Miller, AS Sperling, C Mayerhofer, M McConkey, JM Ellegast, ... Blood Journal, blood. 2023020331, 2023 | 21 | 2023 |
| Synthetic libraries of immune cells displaying a diverse repertoire of chimaeric antigen receptors as a potent cancer immunotherapy W Fu, C Lei, C Wang, Z Ma, T Li, F Lin, R Mao, J Zhao, S Hu Nature Biomedical Engineering 6 (7), 842-854, 2022 | 10 | 2022 |
| TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications C Wang, JYM Tan, N Chitkara, S Bhatt Cancers 16 (17), 3069, 2024 | 7 | 2024 |
| Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts EA Olesinski, KS Bhatia, C Wang, MS Pioso, XX Lin, AM Mamdouh, ... Blood Cancer Discovery, OF1-OF22, 2024 | 6 | 2024 |
| Therapeutic antibodies under development for SARS‐CoV‐2 Z Ma, MM Zhu, S Zhang, K Qian, C Wang, W Fu, C Lei, S Hu View 3 (2), 20200178, 2022 | 5 | 2022 |
| Targeting Mitochondrial Apoptotic Priming State to Personalize Therapy for Relapsed Acute Myeloid Leukemia E Olesinski, K Bhatia, C Wang, M Pioso, SX Ng, XX Lin, V Sandhu, ... Blood 142, 48, 2023 | 1 | 2023 |
| The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies M Yu, GSS Nah, V Krishnan, FNB Sulaimi, KP Ng, C Wang, S Bhatt, ... Leukemia, 1-10, 2024 | | 2024 |
